Lakefront Biotherapeutics (LKFT)
29.52
-0.48
(-1.60%)
USD |
NASDAQ |
Oct 08, 16:00
29.52
0.00 (0.00%)
After-Hours: 20:00
Lakefront Biotherapeutics EPS Diluted (Quarterly) : 0.0349 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0349 |
| March 31, 2026 | 0.2573 |
| December 31, 2025 | 13.81 |
| September 30, 2025 | -3.584 |
| June 30, 2025 | -1.819 |
| March 31, 2025 | -2.450 |
| December 31, 2024 | 0.4097 |
| September 30, 2024 | -0.8407 |
| June 30, 2024 | 0.1468 |
| March 31, 2024 | 1.486 |
| September 30, 2023 | 0.4264 |
| June 30, 2023 | 0.0842 |
| March 31, 2023 | 0.3779 |
| December 31, 2022 | -3.210 |
| September 30, 2022 | 0.3296 |
| June 30, 2022 | -0.3081 |
| March 31, 2022 | -0.2275 |
| December 31, 2021 | 0.2851 |
| September 30, 2021 | -1.162 |
| June 30, 2021 | -1.184 |
| March 31, 2021 | -0.2362 |
| December 31, 2020 | -1.055 |
| September 30, 2020 | -1.464 |
| June 30, 2020 | -1.974 |
| March 31, 2020 | -0.8617 |
| Date | Value |
|---|---|
| December 31, 2019 | -1.977 |
| September 30, 2019 | 6.704 |
| June 30, 2019 | -0.9684 |
| March 31, 2019 | -1.012 |
| December 31, 2018 | 0.3081 |
| September 30, 2018 | 0.3179 |
| June 30, 2018 | -0.5002 |
| March 31, 2018 | -0.8972 |
| December 31, 2017 | -0.6946 |
| September 30, 2017 | -0.852 |
| June 30, 2017 | -0.8273 |
| March 31, 2017 | -0.3106 |
| December 31, 2016 | 1.045 |
| September 30, 2016 | -0.5817 |
| June 30, 2016 | -0.0899 |
| March 31, 2016 | 0.8711 |
| December 31, 2015 | -1.598 |
| September 30, 2015 | -0.7797 |
| December 31, 2005 | -0.0832 |
| September 30, 2005 | -0.2927 |
| June 30, 2005 | 0.00 |
| March 31, 2005 | 0.00 |
| December 31, 2004 | 0.0429 |
| September 30, 2004 | 0.00 |
| June 30, 2004 | -0.1515 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Gilead Sciences, Inc. | -8.444 |
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alkermes Plc | 0.0029 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Amarin Corp. Plc | -0.3681 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 2.260M |
| Revenue (Quarterly) | 14.08M |
| Total Expenses (Quarterly) | 11.82M |
| Enterprise Value | -583.55M |
| Gross Profit Margin (Quarterly) | 24.48% |
| Profit Margin (Quarterly) | 16.05% |
| Earnings Yield | 35.65% |
| Operating Earnings Yield | 34.75% |
| Normalized Earnings Yield | 45.23 |